703 results on '"Nukina, Nobuyuki"'
Search Results
202. Identification of a novel amino-terminal fragment of amyloid precursor protein in mouse neuroblastoma Neuro2a cell
203. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway
204. Expansion of Polyglutamine Induces the Formation of Quasi-aggregate in the Early Stage of Protein Fibrillization
205. Impaired degradation of PKCα by proteasome in a cellular model of Huntington’s disease
206. Down‐regulation of heat shock protein 27 in neuronal cells and non‐neuronal cells expressing mutant ataxin‐3
207. Inhibition of ubiquitin ligase Siah-1A by disabled-1
208. Purification of Polyglutamine Aggregates and Identification of Elongation Factor-1α and Heat Shock Protein 84 as Aggregate-Interacting Proteins
209. A unique origin and multistep process for the generation of expanded DRPLA triplet repeats
210. Assessment of Impaired Proteasomal Function in a Cellular Model of Polyglutamine Diseases.
211. Intra- and Intermolecular β-Pleated Sheet Formation in Glutamine-repeat Inserted Myoglobin as a Model for Polyglutamine Diseases
212. α-Synuclein Affects the MAPK Pathway and Accelerates Cell Death
213. alpha-Synuclein forms a complex with transcription factor Elk-1
214. Studies on sperm whale myoglobin mutants containing inserted glutamine repeats
215. Sandwich ELISA for the measurement of Apo-E4 levels in serum and the estimation of the allelic status of Apo-E4 isoforms
216. Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells
217. Studies on catecholamine by HPLC with multi ECD
218. Foramen magnum syndrome caused by atlanto-occipital assimilation
219. CAG repeat diseases and intranuclear inclusions
220. Huntington's disease gene product, huntingtin, associates with microtubules in vitro
221. Machado–Joseph Disease Gene Product Identified in Lymphocytes and Brain
222. Expression of dentatorubral-pallidoluysian atrophy (DRPLA) proteins in patients
223. Characterization of dentatorubral-pallidoluysian atrophy proteins using two-dimensional electrophoretic analysis
224. PET analysis of a case of cerebrotendinous xanthomatosis presenting hemiparkinsonism
225. Cortical Dysgenesis in a Patient with Turner Mosaicism
226. Abnormal gene product identified in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) brain
227. Cerebellar ataxia and polyneuropathy in a patient with IgM M-protein specific to the Gal(β1-3) GalNAc epitope
228. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
229. Absence of linkage disequilibrium at amyloid precursor protein gene locus in Japanese familia Alzheimer's disease with 717Val→Ile mutation
230. Modulation of voltage-gated K+ channels by the sodium channel β1 subunit.
231. Selection of Behaviors and Segmental Coordination During Larval Locomotion Is Disrupted by Nuclear Polyglutamine Inclusions in a New Drosophila Huntington's Disease-Like Model.
232. Functional reciprocity between Na+ channel NaV1 .6 and β1 subunits in the coordinated regulation of excitability and neurite outgrowth.
233. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1.
234. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.
235. A Functional Null Mutation of SCN1B in a Patient with Dravet Syndrome.
236. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity.
237. Cross-Seeding Fibrillation of Q/N-Rich Proteins Offers New Pathomechanism of Polyglutamine Diseases.
238. Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3.
239. Induction of chemokines, MCP-1, and KC in the mutant huntingtin expressing neuronal cells because of proteasomal dysfunction.
240. STUDIES ON CATECHOLAMINE BY HPLC WITH MULTI ECD
241. Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3.
242. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
243. Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
244. Suppression of Mutant Huntingtin Aggregate Formation by Cdk5/p35 through the Effect on Microtubule Stability.
245. Autophagy-mediated clearance of aggresomes is not a universal phenomenon.
246. Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor.
247. p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
248. Effects of human apolipoprotein E isoforms on the amyloid β-protein concentration and lipid composition in brain low-density membrane domains.
249. Sodium channel β4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice.
250. Expanded polyglutamines impair synaptic transmission and ubiquitin–proteasome system in Caenorhabditis elegans.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.